Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Details)

v3.23.1
Shareholders' Deficit (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
May 01, 2023
Apr. 03, 2023
Feb. 06, 2023
Jan. 17, 2023
Jan. 12, 2022
Jan. 12, 2022
Jan. 06, 2022
May 01, 2021
Dec. 12, 2019
Mar. 24, 2022
Apr. 28, 2021
Aug. 20, 2020
Mar. 31, 2023
Mar. 31, 2022
Sep. 30, 2022
Dec. 31, 2022
Sep. 06, 2022
Jul. 26, 2022
Dec. 31, 2019
Shareholders' Deficit (Details) [Line Items]
Stock based compensation $ 957,556
Dividends $ 8,169 $ 9,147
Accrued dividend payable $ 36,577 $ 74,731
Share issued (in Shares) 22,000,000 773,626 998,008
Restricted stock award granted shares (in Shares) 53,000 500,000
Common shares per share (in Dollars per share) $ 300,000 $ 0.001 $ 0.001
Cash payment $ 275,000
Conversion $ 25,000
Accrued shares (in Shares) 9,636,364
Value of restricted stock common shares $ 14,250
Common shares per share (in Dollars per share) $ 0.0285
Stock-based professional fees $ 22,500 $ 187,690 314,212
Stock-based compensation expense on granted 12,137 $ 42,702
Unrecognized compensation expense 4,046
common stock issued (in Shares) 823,529
Shares of common stock issued (in Shares) 823,529
Debt Discount $ 12,963
Total unrecognized compensation expense related to unvested stock options $ 0 0
Voting percentage 10.00%
Fair market percentage 110.00%
2018 Long-Term Incentive Plan [Member]
Shareholders' Deficit (Details) [Line Items]
Stock option, description The aggregate number of shares of common stock and number of shares of the Company’s common stock that may be subject to incentive stock options granted under the 2018 Plan is 50,000,000 shares, of which 11,445,698 shares have been issued or granted under incentive stock options and 29,451,070 shares of restricted stock have been issued as of March 31, 2023.
Description of options to acquire common stock The exercise price of options granted under our 2018 Plan must at least be equal to the fair market value of the Company’s common stock on the date of grant and the term of an option may not exceed ten years, except that with respect to an incentive stock option granted to any employee who owns more than 10% of the voting power of all classes of the Company’s outstanding stock as of the grant date the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date.
Aggregate shares of common stock (in Shares) 25,000,000
Investor Relations Services [Member]
Shareholders' Deficit (Details) [Line Items]
Value of restricted stock common shares $ 53,000
Common shares per share (in Dollars per share) $ 0.0055
Business Development Services [Member]
Shareholders' Deficit (Details) [Line Items]
Restricted common shares (in Shares) 6,666,667
Business Development [Member]
Shareholders' Deficit (Details) [Line Items]
Value of restricted stock common shares $ 40,000
Common shares per share (in Dollars per share) $ 0.006
Stock-based professional fees $ 29,000 111,800
Issuance of Common Stock for Professional Fees [Member]
Shareholders' Deficit (Details) [Line Items]
Value of restricted stock common shares $ 11,667
Common shares per share (in Dollars per share) $ 28,333
Series B Preferred Stock [Member]
Shareholders' Deficit (Details) [Line Items]
Designations established share (in Shares) 100,000
Preferred Stock value (in Shares) 0.1
Stated value $ 1,000
Preferred Stock dividend rate 2.00%
Stock option, description The Series B is convertible into common stock at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion Price for a period of twenty consecutive trading days, at the option of the Company. Conversion Price means a price per share of the common stock equal to 100% of the lowest daily volume weighted average price of the common stock during the two years preceding or subsequent two years following the Issuance Date, subject to adjustment as otherwise provided in the Certificate of Designations (the “Conversion Price”).
Accrued compensation $ 278,654 $ 144,000
Accrued compensation shares (in Shares) 278 144
Vested shares (in Shares) 158
Dividends $ 5,518 4,858
Preferred stock balance $ 1,037,201 $ 1,803,731
Stated value 1,000,624 $ 1,729,000
Series C Preferred Stock [Member]
Shareholders' Deficit (Details) [Line Items]
Designations established share (in Shares) 100,000
Preferred Stock value (in Shares) 0.1
Stated value $ 100 1,627,600
Preferred Stock dividend rate 2.00%
Preferred stock balance $ 1,186,719 $ 1,710,500
Stated value 1,144,623
Accrued dividend payable $ 82,900 $ 42,096
Percentage of stated value 150.00%
Outstanding shares percent 4.99%
Share issued (in Shares) 1,543,151 1,543,151
Common shares converted (in Shares) 120 120 1,014
Stated redemption value $ 12,000 $ 12,000 $ 101,400
Shares issued (in Shares) 26,585,614
Subscription Agreements [Member]
Shareholders' Deficit (Details) [Line Items]
Restricted stock award granted shares (in Shares) 54,545,455
Common Stock Issued for Cash and Accrued Compensation [Member]
Shareholders' Deficit (Details) [Line Items]
Common shares per share (in Dollars per share) $ 0.0055
Common Stock Issued for Conversion of Series C Preferred Stock [Member]
Shareholders' Deficit (Details) [Line Items]
Share issued (in Shares) 1,543,151 1,543,151 26,585,614
Common shares converted (in Shares) 1,014
Stated redemption value $ 101,400
Shares Issued for Accounts Payable [Member]
Shareholders' Deficit (Details) [Line Items]
Common shares per share (in Dollars per share) $ 0.024
Company issued (in Shares) 90,859
Accounts payable $ 2,174
Forecast [Member] | Series B Preferred Stock [Member]
Shareholders' Deficit (Details) [Line Items]
Vested shares (in Shares) 842